Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02HVW
|
||||
Former ID |
DCL000665
|
||||
Drug Name |
Zibotentan
|
||||
Synonyms |
ZD4054; ZD-4054; ZD4054, Zibotentan; Zibotentan (JAN/INN); Trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid; N-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H16N6O4S
|
||||
InChI |
InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)
|
||||
InChIKey |
FJHHZXWJVIEFGJ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 23713-49-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
14880486, 24190808, 45981884, 50077277, 68529939, 74721089, 85210245, 87550958, 93310545, 96024464, 99437161, 112379018, 124757263, 124950684, 124966603, 125164067, 125719303, 126651455, 126671547, 127855448, 131480882, 134339186, 135260946, 135368547, 136367429, 136920383, 137025840, 137275851, 141774639, 152048791, 152258082, 152344311, 160646921, 162011975, 162037610, 162202699, 162807569, 177748946, 178100518, 185998560, 196408601, 198974084, 223383997, 223662579, 223705164, 227118911, 242555952, 249582457, 249814523, 252216640
|
||||
ChEBI ID |
ChEBI:29105
|
||||
Target and Pathway | |||||
Target(s) | Endothelin-1 receptor | Target Info | Antagonist | [550288] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Endothelin signaling pathway | ||||
Pathway Interaction Database | Endothelins | ||||
EGFR-dependent Endothelin signaling events | |||||
References | |||||
Ref 540471 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3539). | ||||
Ref 546670 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009560) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.